Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ABBV-400 |
Trade Name | |
Synonyms | ABBV 400|ABBV400 |
Drug Descriptions |
ABBV-400 is an antibody-drug conjugate (ADC) comprising an anti-MET monoclonal antibody conjugated to a topoisomerase inhibitor, which potentially inhibits tumor growth (Cancer Res (2023) 83 (7_Supplement): 6311). |
DrugClasses | MET Antibody 31 |
CAS Registry Number | NA |
NCIT ID | C184368 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ABBV-400 | ABBV-400 | 0 | 2 |
ABBV-400 + Bevacizumab | ABBV-400 Bevacizumab | 0 | 1 |
ABBV-400 + Bevacizumab + Fluorouracil + Leucovorin | ABBV-400 Bevacizumab Fluorouracil Leucovorin | 0 | 1 |